Pernicious cachexia: a different view of cancer

Area of Science:

• Oncology
• Metabolic Medicine
• Cancer Biology

Background:

• Breast cancer mortality has remained stagnant for decades, indicating treatment limitations.
• Current breast cancer treatments are based on the premise that the tumor is the sole threat, neglecting systemic aspects.
• Hallmarks of cancer like cachexia and paraneoplasia are often overlooked or misattributed to tumor effects.

Purpose of the Study:

• To propose a new hypothesis for cancer, viewing it as a systemic metabolic deficiency rather than solely a local tumor problem.
• To explain the failure of conventional cancer treatments by re-evaluating the role of tumors.
• To suggest that tumors may serve a protective, compensatory function in response to a depleted vital substance.

Main Methods:

• Conceptual re-evaluation of cancer as a systemic metabolic disease.
• Analogy drawn between cancer and other systemic diseases like arteriosclerosis and pernicious anemia.
• Hypothesizing the role of carcinogens in depleting vital substances and inducing metabolic deficiency.

Main Results:

• Cancer is proposed to be a systemic condition characterized by metabolic deficiency and cachexia, with the tumor acting as a compensatory organ.
• Tumor growth is hypothesized to increase as the metabolic deficiency worsens, attempting to replenish a lost vital substance.
• The failure of current treatments is explained by their focus on local tumor removal without addressing the underlying systemic metabolic issue.

Conclusions:

• Cancer should be viewed as pernicious cachexia driven by the loss of a vital metabolite, with the tumor providing compensation.
• Treatment strategies should consider preserving the tumor and managing secondary manifestations until the underlying metabolic deficiency is understood and addressed.
• Further research is needed to identify the specific vital substance depleted in cancer and its metabolic role.